ArticleJHEP reports : innovation in hepatology2025

Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab.

Meng Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.